GT

Ganesh Tejramji Jumle

Active Director Director DIN 10352233
DIN 10352233 First appointment Oct 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Ganesh Tejramji Jumle

Data last updated:

Ganesh Tejramji Jumle is a Director at Medicruze Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10352233
Primary Designation Director
Industry Pharma
First Appointment 12 Oct 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Oct 20232023Active

Board colleagues of Ganesh Tejramji Jumle

NameDINCompanyDesignation
Mamata Ganesh Jumle10352234Medicruze Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medicruze Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ganesh Tejramji Jumle

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ganesh Tejramji Jumle

Ganesh Tejramji Jumle currently holds 1 directorship: Medicruze Pharmaceuticals Private Limited (Director, since 12 Oct 2023).

Ganesh Tejramji Jumle was first appointed on 12 Oct 2023 as Director at Medicruze Pharmaceuticals Private Limited.

The current boards of Ganesh Tejramji Jumle's companies include Mamata Ganesh Jumle (Medicruze Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available